Merck Animal Health is expanding its international business with the acquisition of South American and Turkish vaccine manufacturers.<\/p>\n
Madison, New Jersey-based Merck reported Dec. 6 that it purchased Prondil S.A. of Montevideo, Uruguay. Privately held Prondil develops and manufactures livestock vaccines and antigens for sale in more than 20 countries.<\/p>\n
In mid-November, Merck agreed to acquire Vilsan Pharmaceuticals, which makes drugs and vaccines for livestock, poultry and fish. Vilsan, also privately held, is headquartered in Istanbul, Turkey, and operates a factory in Ankara.<\/p>\n
The transaction terms were not announced.<\/p>\n
Merck Animal Health is striving \u201cto expand our vaccine leadership and add more breadth to our portfolio,\u201d President Rick DeLuca said.<\/p>\n
\u201cThis acquisition of Prondil provides expertise and biologics manufacturing capacity as well as a complementary portfolio of specialized livestock vaccines,\u201d DeLuca said.<\/p>\n
The addition of Vilsan \u201cwill bring value and new options to our customers in this growing region,\u201d said Philippe Houffschmitt, general manager of MSD Animal Health Turkey.<\/p>\n","protected":false},"excerpt":{"rendered":"
Prondil S.<\/p>\n","protected":false},"author":45,"featured_media":1758,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"_acf_changed":false,"iawp_total_views":0,"footnotes":""},"categories":[90],"tags":[],"class_list":["post-1757","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-online","column-news","clinical_topics-news"],"acf":{"hide_sidebar":false,"hide_sidebar_ad":false,"hide_all_ads":false},"yoast_head":"\n